Genitourinary Oncologist Dr. Toni K. Choueiri on the METEOR Study and Advances in GU Therapies
Investigators are only as productive and strong as the members of their team. That is only one of many nuggets of wisdom from Dr. Toni K. Choueiri in this lively ACCRU podcast episode. Dr. Choueiri is the Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute (DFCI), co-leader of the Kidney Cancer Program at Dana-Farber/Harvard Cancer Center, and the Jerome and Nancy Kohlberg Chair and Professor of Medicine at Harvard Medical School. He is also a member of the ACCRU Board of Directors. Dr. Choueiri also discusses the success of the phase 3 METEOR trial and what excites him about the progress in GU oncology. His insights on the work itself of an investigator are invaluable: the importance of facing the truth that success is not serendipity but the result of hard work and knowledge over time.
Create your
podcast in
minutes
It is Free